Ketryx raises $14m in Series A funding
This article originally appeared in Med-Tech Innovation News on December 5, 2024.
The round was led by investor Lightspeed Venture Partners, with participation from existing investors including MIT’s E14 Fund and Ubiquity Ventures, bringing the total funding raised to date to over $18 million. Lightspeed partner Guru Chahal will join the board. The new funds will be used to accelerate product development and commercial expansion.
The healthcare industry is embracing software and its promise to improve patient outcomes, including the power of Artificial Intelligence/Machine Learning (AI/ML). As a result, companies are grappling with how to maintain quality assurance and regulatory compliance as more frequent software updates are required and software complexity grows.
Ketryx founder and CEO Erez Kaminski, said: “Our mission is to enhance medical software safety and reliability, reducing recalls and improving patient outcomes. Quality assurance is becoming more complex as software and AI rapidly permeate the healthcare industry. We’re thrilled to partner with Lightspeed to further our mission, expand access to our platform, and meet the fast-growing market demand.”
Traditional manual approaches to software quality assurance are now inadequate and increasingly prone to human errors that could result in injury or death. The solution is to integrate automation and quality process enforcement into the software development lifecycle and quality processes. This ensures teams follow best practices and proactively empowers them to identify and mitigate risks before they affect performance.
